Saturday, July 11, 2026

Drug profile · INN

cetirizine

cetirizine (ALZENE) is a histamine h1 receptor antagonist. Associated with Alphapharm Pty Ltd.

TGA: approved
Patents linked 0
Pipeline programs 10
News articles 0
Drug details — cetirizine

Quick answer

cetirizine (ALZENE) is a histamine h1 receptor antagonist. Associated with Alphapharm Pty Ltd.

Key facts

INN cetirizine
Brand ALZENE
Mechanism Histamine H1 receptor antagonist

Mechanism of action

Histamine H1 receptor antagonist

Approval history

Authority Status Date
TGA approved

Pipeline programs

  1. 299IG301 Phase 3 · Biogen · IgA nephropathy
  2. Cetirizine Phase 3 · BRIGHT MINDS BIOSCIENCES · COVID-19
  3. TG1101-RMS401 Phase 3 · TG THERAPEUTICS · Relapsing multiple sclerosis
  4. NN6019-7565 Phase 2 · NovoThirteen · Participants with transthyretin amyloid cardiomyopathy (ATTR
  5. TCD17197 Phase 2 · Sanofi-Aventis U.S · Acute lymphocytic leukaemia- Acute myeloid leukaemia refract
  6. mRNA 3210-P101 Phase 2 · SOM Biotech · Participants with Phenylketonuria
  7. mRNA-3745-P102 Phase 2 · SOM Biotech · Glycogen storage disease type 1a (GSD1a)
  8. mRNA-3927-P101 Phase 2 · SOM Biotech · Propionic Acidemia

Frequently asked questions

What is cetirizine?

cetirizine (ALZENE) is a histamine h1 receptor antagonist. Associated with Alphapharm Pty Ltd.

What is the brand name for cetirizine?

ALZENE is a marketed brand name for cetirizine. Check FDA Drugs@FDA for the current US label holder and prescribing information.